BlackRock
CAI

BlackRock’s Caris Life Sciences CAI Stock Holding History

BlackRock’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.7M Buy
5,536,798
+679,686
+14% +$12.2M ﹤0.01% 2236
2026
Q1 		$86.8M Buy
4,857,112
+2,485,876
+105% +$54.3M ﹤0.01% 2191
2025
Q4 		$64M Buy
2,371,236
+1,724,155
+266% +$48.6M ﹤0.01% 2368
2025
Q3 		$19.6M Buy
647,081
+337,979
+109% +$10.8M ﹤0.01% 3095
2025
Q2 		$8.26M Buy
+309,102
New +$8.33M ﹤0.01% 3510

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock's CAI Position: Q2 2026 in Review

BlackRock increased its Caris Life Sciences (CAI) stake by 14% in Q2 2026, buying an estimated $12.2M and bringing the position to 5,536,798 shares worth $98.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

BlackRock first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • BlackRock held 5,536,798 shares of Caris Life Sciences worth $98.7M as of Q2 2026.
  • BlackRock bought 679,686 Caris Life Sciences shares in Q2 2026, an estimated $12.2M.
  • Caris Life Sciences made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2236 holding.
  • BlackRock first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.